You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

First-In-Class Investigational Agent

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

C04.588.274.476.411.307 Trial (CPI-613, modified FFX, Bevacizumab)

Not yet recruiting
  • C04.588.274.476.411.307
  • (no location specified)
Nov 10, 2022

Class II Div 1 Malocclusion Trial in Rohtak (maxillary Ist premolar extraction, SURGICAL)

Recruiting
  • Class II Div 1 Malocclusion
  • maxillary Ist premolar extraction
  • SURGICAL
  • Rohtak, Haryana, India
    Sonal Chowdhary
Nov 28, 2022

Cancer Trial in L'Hospitalet de Llobregat (MBF-362)

Recruiting
  • Cancer
  • L'Hospitalet de Llobregat, Barcelona, Spain
    Instituto Catalan de Oncología
Jul 7, 2023

Class III Malocclusion Trial (the mandible first, the maxilla first)

Completed
  • Class III Malocclusion
  • the mandible first
  • the maxilla first
  • Cairo, Middle East, Egypt
    Cairo University
Oct 18, 2022

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer Trial (Tislelizumab, BGB-A425, LBL-007)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Head and Neck Cancer
  • (no location specified)
Jun 9, 2023

Malignant Tumor, Advanced Solid Tumor, Glioblastoma Multiforme Trial in Milano (PhOx430)

Recruiting
  • Malignant Tumor
  • +3 more
  • Milano, Italy
    IRCCS Ospedale San Raffaele
Aug 8, 2022

Triple Negative Breast Cancer, Clear Cell Renal Cell Carcinoma, Ovarian Cancer Trial in Austin, San Antonio, Fairfax (BDC-3042,

Recruiting
  • Triple Negative Breast Cancer
  • +5 more
  • Austin, Texas
  • +2 more
Sep 19, 2023

Face Mask, Rapid Maxillary Expansion, Maxillary Retrognathism Trial in Edirne (Delaire Face Mask (M0774-01, Leone S.p.A.,

Completed
  • Face Mask
  • +2 more
  • Delaire Face Mask (M0774-01, Leone S.p.A., Florence, Italy) for first group
  • +2 more
  • Edirne, Turkey
    Trakya University
Jun 16, 2023

Advanced Solid Malignancies Trial in Irving (GIM122)

Not yet recruiting
  • Advanced Solid Malignancies
  • Irving, Texas
    NEXT Dallas
Sep 8, 2023

Class II Malocclusion Trial in New Cairo (Intra-Oral Distalizing Device)

Active, not recruiting
  • Class II Malocclusion
  • Intra-Oral Distalizing Device
  • New Cairo, Cairo, Egypt
    Future University In Egypt
Nov 29, 2022

Metastatic Solid Tumor Cancer Trial in Caen, Paris, Villejuif (Dose escalation, first-in-human phase I clinical trial with an

Recruiting
  • Metastatic Solid Tumor Cancer
  • Dose escalation, first-in-human phase I clinical trial with an Expansion phase
  • Caen, France
  • +2 more
Oct 11, 2022

Advanced Adult Hepatocellular Carcinoma Trial in Chicago, Ann Arbor, Dallas (Cabozantinib)

Recruiting
  • Advanced Adult Hepatocellular Carcinoma
  • Chicago, Illinois
  • +3 more
Aug 15, 2022

Class II Malocclusion Trial in Cairo (Distalization combined with upper third molars extraction, Distalization without upper

Completed
  • Class II Malocclusion
  • Distalization combined with upper third molars extraction
  • Distalization without upper third molars extraction
  • Cairo, Egypt
    Future University in Egypt
Dec 8, 2022

Multiple Myeloma Trial in Japan (Isatuximab SAR650984)

Completed
  • Multiple Myeloma
  • Isatuximab SAR650984
  • Nagoya-shi, Aichi, Japan
  • +12 more
Nov 22, 2022

Recurrent Pregnancy Loss Trial in Aalborg

Recruiting
  • Recurrent Pregnancy Loss
    • Aalborg, Denmark
      The Centre for Recurrent Pregnancy Loss of Western Denmark, Depa
    Apr 30, 2022

    Tumor Malignant Trial in Worldwide (SAR443216)

    Recruiting
    • Neoplasm Malignant
    • Houston, Texas
    • +7 more
    Jul 13, 2022

    Human Cancers Trial in Cambridge, London (MOv18 IgE)

    Completed
    • Human Cancers
    • MOv18 IgE
    • Cambridge, United Kingdom
    • +2 more
    May 19, 2022

    Hematologic Malignancy Trial in Guangzhou (BC3402 Injection)

    Not yet recruiting
    • Hematologic Malignancy
    • BC3402 Injection
    • Guangzhou, Guangdong, China
      The First Affiliated Hospital of Jinan University
    Jan 10, 2023

    Locally Advanced or Metastatic HER2-Expressing Cancers Trial in Australia, Spain (AMX 818, Pembrolizumab)

    Recruiting
    • Locally Advanced or Metastatic HER2-Expressing Cancers
    • Melbourne, Australia
    • +9 more
    Jan 16, 2023

    Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor Grade 1 Trial ([203Pb]VMT-a-NET, SPECT/CT)

    Enrolling by invitation
    • Neuroendocrine Tumor Grade 2
    • Neuroendocrine Tumor Grade 1
    • Iowa City, Iowa
      The University of Iowa
    Dec 9, 2022

    Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome Trial in Australia, Netherlands,

    Recruiting
    • Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome
    • Duarte, California
    • +12 more
    Jan 4, 2023

    Pancreas Cancer Trial in New York (Pembrolizumab, Azacitidine)

    Active, not recruiting
    • Pancreas Cancer
    • New York, New York
      Columbia University Irving Medical Center
    Nov 29, 2022

    Oesophageal Carcinoma Trial in Australia (APR-246)

    Terminated
    • Oesophageal Carcinoma
    • Clayton, Victoria, Australia
    • +4 more
    Dec 10, 2021

    Relapsed/Refractory Multiple Myeloma Trial in Benowa (ISB 2001)

    Not yet recruiting
    • Relapsed/Refractory Multiple Myeloma
    • ISB 2001
    • Benowa, Queensland, Australia
      Pindara Private Hospital
    May 18, 2023

    Healthy Trial in Miami (RVP-001, Placebo)

    Active, not recruiting
    • Healthy
    • Miami, Florida
      Quotient Sciences
    Jul 30, 2022